IL-8 plays an important role in tumor growth and metastasis, and is associated with tumor burden in melanoma, renal cell cancer, and hepatocellular carcinoma in vivo models and with worse prognosis in advanced solid tumors including OvCa (44–46). Here, CXCL8 is linked to melanoma.